Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
302
-
Total 13F shares, excl. options
-
83.8M
-
Shares change
-
-3.15M
-
Total reported value, excl. options
-
$1.32B
-
Value change
-
-$49.9M
-
Put/Call ratio
-
0.21
-
Number of buys
-
121
-
Number of sells
-
-121
-
Price
-
$15.71
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q2 2023
348 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q2 2023.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 302 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 83.8M shares
.
Largest 10 shareholders include Capital Research Global Investors (13.8M shares), MORGAN STANLEY (4.78M shares), GOLDMAN SACHS GROUP INC (4.73M shares), Mondrian Investment Partners LTD (4.08M shares), MACQUARIE GROUP LTD (3.83M shares), RENAISSANCE TECHNOLOGIES LLC (3.65M shares), MILLENNIUM MANAGEMENT LLC (3.09M shares), Clal Insurance Enterprises Holdings Ltd (2.78M shares), FMR LLC (2.48M shares), and BlackRock Inc. (2.41M shares).
This table shows the top 302 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.